Rhopressa (netarsudil ophthalmic solution) 0.02%, is a novel once-daily eye drop for the lowering of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Rhopressa is believed to reduce IOP by increasing the outflow of aqueous humor (the fluid inside the eye) through the trabecular meshwork, the main fluid drain of the eye.
Rhopressa (netarsudil ophthalmic solution) is a Rho kinase inhibitor for the treatment of open-angle glaucoma or ocular hypertension. Use one drop in the affected eye(s) once daily in the evening. If a dose is missed, treatment should continue with the next dose in the evening. Avoid allowing the tip of the dropper to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution.
Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions. Rhopressa contains benzalkonium chloride, which may be absorbed by soft contact lenses. Contact lenses should be removed prior to instillation of Rhopressa and may be reinserted 15 minutes following its administration.
If more than one topical ophthalmic drug is being used, the drugs should be administered at least 5 minutes between applications. The most common side effect is eye redness. Other common side effects include corneal verticillata, pain at the instillation site, and conjunctival hemorrhage.
haleplushearty.blogspot.com
No comments:
Post a Comment